Adaptive Biotechnologies: Strong Sequencing, Weak Margin Of Safety [Seeking Alpha]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: Seeking Alpha
Q4 revenue beat expectations with 51% Y/Y growth, yet shares declined as 2026 MRD guidance implies a slowdown to 22% growth. My discounted cash flow analysis flags ADPT as overvalued by 40%, with the current price reflecting little margin of safety. I maintain a cautious 'Hold' rating, as upside depends on faster margin expansion or IM/Pfizer outperformance, both uncertain. FangXiaNuo/E+ via Getty Images Overview I'm revisiting Adaptive Biotechnologies Corporation ( ADPT ) today. This is a company I've now covered for over two years. They sell products in the minimal residual disease [MRD] market, which is very competitive, but as I noted in my This article is intended to provide informational content and should not be viewed as an exhaustive analysis of the featured company. It should not be interpreted as personalized investment advice with regard to "Buy/Sell/Hold/Short/Long" recommendations. Financial models presented here, including DCF, rNPV, and scenario analyses,
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means [Yahoo! Finance]Yahoo! Finance
- Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026GlobeNewswire
ADPT
Earnings
- 2/5/26 - Beat
ADPT
Sec Filings
- 4/16/26 - Form 4
- 4/13/26 - Form 4
- 4/10/26 - Form 4
- ADPT's page on the SEC website